Cactus Life Sciences
Cactus Life Sciences has begun their exciting buy-and-build strategy adding key services to their portfolio
PRINCETON, NJ / ACCESSWIRE / April 24, 2024 / Cactus Life Sciences, a leading global scientific communications agency that works with blue chip pharma and biotechnology companies, announced today that they have acquired nspm and eluSCIdate, two dynamic medical communications and publications companies headquartered in Meggen, Switzerland with an office in the UK.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.logo lockup
Cactus Life Sciences, headquartered in Princeton, New Jersey, was formed in 2010 and is best known for its transformational global operating models that provide best in class science, innovation, and efficiency. Founded 27 years ago, nspm brings extensive expertise in medical communications, publications, and event management, with a focus on rare diseases. Its sister company eluSCIdate was founded in 2020 and focuses on medical and scientific publications, combining extensive experience in medical writing with creative flair to deliver high-quality publications.
This collaboration signifies a major step forward in enhancing services for our biopharma clients, ensuring a comprehensive and fully integrated global approach to medical communications. And provides a significant employee footprint in US, UK, Switzerland, and Japan.
"As Cactus Life Sciences embarks on its forthcoming buy-and-build strategy, we're excited to unveil our first acquisition that shares so many of the same values as CACTUS, stated Oliver Dennis, the new Chairman of Cactus Life Sciences. "As we move forward, we seek partnerships that prioritize our people and clients alongside our strategic growth."
Rare diseases individually affect a small number of people, but collectively affect over 300 million worldwide, presenting significant challenges for patients and medical professionals. nspm's rare disease expertise addresses unmet needs for patients and society. Sabine Stotz, PhD, Managing Director, nspm, noted "This strategic alliance is a testament to the shared vision of excellence between Cactus Life Sciences, nspm and eluSCIdate. Together, our goal is to enrich the global landscape of scientific communications creating an even greater impact on healthcare professionals and the patients they treat".
Elvira Dsouza, President, Cactus Life Sciences remarked, "Cactus Life Sciences stands out for its unwavering commitment to excellence, innovation, and future readiness. With a focus on integrating cutting-edge technology, notably AI, we aim to elevate scientific content creation to contribute to a more accessible, informed, and transformative healthcare landscape".
About Cactus Life Sciences (cactuslifesciences.com): Cactus Life Sciences is a medical communication company that provides scientific strategy and content across the healthcare continuum, anywhere in the world ─ with a focus on science, innovation, and efficiency. We work alongside leading healthcare companies to establish the optimal role of medicines and encourage positive behaviors (physician and patient) that improve patient outcomes.
About nspm (www.nspm.com): nspm is a successful and dynamic medical communications company founded in 1997 with offices in Switzerland and the UK. nspm provides a complete range of medical writing, project management, and strategic medical communications solutions for the pharmaceutical and biotech industry across a range of therapeutic areas, with a focus on rare diseases. Our employees are committed to crafting high-quality, cost-effective solutions that exceed clients' expectations through scientific excellence, professionalism, and creativity.
About eluSCIdate (www.eluscidate.com): eluSCIdate is a medical writing agency founded in 2020 that specializes in scientific publications, providing support for the entire publication process. We use a wealth of experience in medical writing to deliver high-quality manuscripts, posters, and slides to our clients. At eluSCIdate, we are passionate about science and committed to providing clarity in scientific messaging. Through effective communication, we work with our clients to ensure their science stands out from the crowd.
Contact Information:
Laura Perry
VP of Strategy and Marketing
inquiries@cactuslifesciences.com
7327121005
SOURCE: Cactus Life Sciences
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
GoodData Rolls Out AI Assistant: Embeddable Generative Analytics You Can Trust29.5.2025 08:30:00 CEST | Press release
Next-Gen Conversational Analytics Now Available, Secure, and Fully Embeddable SAN FRANCISCO, CA / ACCESS Newswire / May 29, 2025 / GoodData today announced the general availability of GoodData AI Assistant, a conversational analytics solution that transforms how business users engage with data. Built to scale, the AI Assistant enables users to ask questions in plain language and receive precise, governed insights right where decisions are made. As a flagship feature of the GoodData AI platform, the AI Assistant redefines how organizations unlock value from analytics. It blends the power of generative AI with semantic context and robust enterprise controls, making data exploration faster, smarter, and secure by design. Conversational Analytics at Enterprise Scale With the release of GoodData AI Assistant, organizations gain access to a conversational interface that brings AI-driven data exploration to every user, without compromising governance or performance. With the launch of AI Assi
Quasar Medical Will Acquire Nordson MEDICAL Design and Development Business in Galway, Ireland, and Tecate, Mexico29.5.2025 07:30:00 CEST | Press release
Quasar Grows Global Full-Lifecycle CDMO Platform; Nordson MEDICAL Sharpens Focus on Core Components Business SAINT PAUL, MINNESOTA / ACCESS Newswire / May 29, 2025 / Quasar Medical, a global leader in the manufacturing of interventional and complex minimally invasive devices, announced it has signed a definitive agreement with Nordson Corporation (NASDAQ:NDSN) to acquire its design and development contract manufacturing businesses in Galway, Ireland, and Tecate, Mexico. This will strengthen Quasar's global position as a full-service Contract Development and Manufacturing Organization (CDMO), offering end-to-end solutions from initial design to large-scale production. The deal is expected to close in the third quarter of calendar 2025. The Galway and Tecate facilities will be integrated into Quasar's expanding global platform, adding specialized expertise in complex balloon and catheter design, rapid prototyping, and cost-efficient device near-shore assembly. Both sites provide Quasar w
IPRoyal Survey Highlights Inflation as Top Driver of Retail Pricing Decisions Amid Margin Pressure28.5.2025 09:00:00 CEST | Press release
Outdated Manual Tracking Holds Back Pricing Agility as 95% of Companies Face Price-Sensitive Customers NEW YORK, NY / ACCESS Newswire / May 28, 2025 / IPRoyal, a leading provider of residential proxies and other IP address solutions, today released the results of its 2025 Pricing Strategy Survey, based on responses from 675 manager-level professionals in organizations of more than 500 employees. The findings reveal that inflation is the top factor influencing pricing strategies (cited by 75 percent of respondents) as businesses work to protect themselves from shrinking profit margins and navigate ongoing market uncertainty. The survey also reveals a critical gap: while companies face mounting pressure to stay competitive, many have yet to fully adopt the tools needed to make faster, more accurate pricing decisions. Nearly all respondents (95 percent) said their customers are moderately to extremely price sensitive, highlighting the need for precise, dynamic pricing strategies. Yet, mor
Star Copper Announces Uplisting to OTCQB Venture Market28.5.2025 03:01:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / May 28, 2025 / Star Copper Corp. (CSE:STCU)(OTC PINK:STCUF)(FWB:SOP) ("Star Copper" or the "Company"), a Canadian resource exploration and development company, is pleased to announce that its common shares have been approved for trading on the OTCQB Venture Market, a U.S. trading platform operated by the OTC Markets Group in New York. The shares will commence trading on the OTCQB under the symbol "STCUF" as of market open on May 28, 2025. The Company will continue to trade on the Canadian Securities Exchange under the symbol "STCU" and on the Frankfurt Stock Exchange under "SOP". The uplisting to the OTCQB Venture Market represents a significant milestone for Star Copper, improving visibility, transparency, and accessibility for U.S. investors. The OTCQB Venture Market is designed for early-stage and developing U.S. and international companies and is recognized for providing current public information and audited financials, enhancing investor confiden
GoodData Launches GoodData AI: Embed, Extend, and Scale Analytics with AI27.5.2025 08:30:00 CEST | Press release
AI-Native Analytics Platform That Understands Your Business - and Your Developers SAN FRANCISCO, CA / ACCESS Newswire / May 27, 2025 / GoodData today announced the general availability of GoodData AI, a next-generation analytics platform that places AI at every layer of the data stack - from raw-data ingestion to governed insight delivery - without compromising trust or compliance. Why GoodData AI Stands Apart GoodData AI is designed for enterprises that require trust, scalability, and extensibility. Its architecture is built around these foundational principles: Composable by design: Embedded, white-labeled, and API-first; built for developers to connect with any AI stack. Semantic layer and ontology: The only AI analytics engine that natively understands your business logic, ensuring every answer is both consistent and metric-perfect. Model Context Protocol (MCP) Support: Enables real-time, cross-system context that makes AI relevant. GoodData's new MCP Server Beta program is now ava
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom